12:00 AM
 | 
Aug 07, 2000
 |  BC Week In Review  |  Company News  |  Deals

Creative BioMolecules, Ontogeny, Reprogenesis deal

CBMI shareholders approved its merger with Ontogeny and Reprogenesis to form regenerative medicine company Curis Inc. (see BioCentury, Feb....

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >